| Literature DB >> 32111061 |
Elwira Sieniawska1, Rafał Sawicki2, Joanna Golus2, Milen I Georgiev3,4.
Abstract
The antimycobacterial activity of cinnamaldehyde has already been proven for laboratory strains and for clinical isolates. What is more, cinnamaldehyde was shown to threaten the mycobacterial plasma membrane integrity and to activate the stress response system. Following promising applications of metabolomics in drug discovery and development we aimed to explore the mycobacteria response to cinnamaldehyde within cinnamon essential oil treatment by untargeted liquid chromatography-mass spectrometry. The use of predictive metabolite pathway analysis and description of produced lipids enabled the evaluation of the stress symptoms shown by bacteria. This study suggests that bacteria exposed to cinnamaldehyde could reorganize their outer membrane as a physical barrier against stress factors. They probably lowered cell wall permeability and inner membrane fluidity, and possibly redirected carbon flow to store energy in triacylglycerols. Being a reactive compound, cinnamaldehyde may also contribute to disturbances in bacteria redox homeostasis and detoxification mechanisms.Entities:
Keywords: LC-MS; metabolic pathways; metabolomics; mycobacterial lipids
Mesh:
Substances:
Year: 2020 PMID: 32111061 PMCID: PMC7175327 DOI: 10.3390/biom10030357
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1Cloud plot analysis of hydrophilic (H) and lipophilic (L) Mtb whole cell extracts analyzed in positive (POS) and negative (NEG) mode. Fold change > 1.5; p < 0.01. The color of the bubble denotes directionality of fold change and the size of the bubble denotes the extent of the fold change. Green color represents up-regulated metabolite features, while red color represents down-regulated metabolite features.
Figure 2Principal component analysis (PCA) plot of the features detected in test (cinnamaldehyde) and control (untreated) cultures of Mtb; hydrophilic (H) and lipophilic (L) extract; positive (POS) and negative (NEG) mode. Red dots–untreated samples, blue dots–cinnamon essential oil/cinnamaldehyde samples, circles indicate grouped point sets.
Activity network (connections) obtained for bacteria under the treatment of cinnamaldehyde.
| KEGG Pathway Name and Metabolites | Total | Hits | |
|---|---|---|---|
| tetrahydrofolate biosynthesis: | 2 | 2 | 0.012 |
| 7,8-dihydrofolate | (42.4 up) | ||
| 7,8-dihydropteroate | (9.7 up) | ||
| tRNA charging: | 4 | 2 | 0.03 |
| L-histidine | (3.2 down) | ||
| L-tyrosine | (3.2 down) | ||
| factor 420 biosynthesis: | 2 | 2 | 0.03863 |
| 5-amino-6-(D-ribitylamino)uracil | (9.1 down) | ||
| 5,10-methylene-tetrahydromethanopterin | (162.3 up ) | ||
| biotin biosynthesis from 8-amino-7-oxononanoate I: | 2 | 2 | 0.03863 |
| S-adenosyl-4-methylthio-2-oxobutanoate | (4.2 down) | ||
| 8-amino-7-oxononanoate | (12.8 down) |
Figure 3The number of different m/z up-regulated or down-regulated under the influence of CA (versus untreated) assigned to a given lipid class. Blue and red bars represent up-regulated and down-regulated features, respectively. MA–Mycolic acids; DIMA–Phthiocerol dimycocerosates; GMM–Glucose monomycolates; MBFA–Methyl branched fatty acids; MG–Monoacylglycerols; DG–Diacylglycerols; TG–Triacylglycerols; Lyso-GP–Monoacylglycerophosphoglycerols; Lyso-PE–Monoacylglycerolphosphoethanolamines; Lyso-PIM1–Monoacylglycerophosphoinositolmonomannosides; Lyso-PI–Monoacylglycerophosphoinositols; PIM4–Diacylglycerophosphoinositoltetramannosides; PIM3–Diacylglycerophosphoinositoltrimannosides; PIM2–Diacylglycerophosphoinositoldimannosides; Ac1PIM1–Monoacylated diacylglycerophosphoinositolmonomannosides; Ac1PIM3–Monoacylated diacylglycerophosphoinositolmonotrimannosides; Ac2PIM2–Diacylated diacylglycerophosphoinositoldimannosides; PG–Diacylglycerophosphoglycerols; PI–Diacylglycerophosphoinositols; CL–Diacylglycerophosphoglycerophosphodiradylglycerols; PE–Diacylglycerolphosphoethanolamines; MPM–Mannosyl-b1-phosphomycoketides; Ac2SGL–Diacylated Sulfolipid; DAT2–2,3-di-O-acyltrehaloses; DAT1–2,3-di-O-acyltrehaloses; SL-III–Sulfolipid III.